Clinical Trial

Early Rehabilitation in Patients on Extracorporeal Membrane Oxygenation

Study acronym: ECMO-Rehab
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 10, 2024 (before its estimated May 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Critically ill patients who require extracorporeal membrane oxygenation (ECMO) are the sickest in the hospital. More patients are surviving but survivors have compromised functional recovery for months or years. This registry-embedded randomised trial aims to determine if early rehabilitation commenced within 72 hours of ECMO is feasible and improves muscle strength and functional status in patients compared to standard practice in a randomised controlled trial of 100 ICU patients. The effect of the intervention on mortality, health status, and function at 180 days will be evaluated, as well as cost-effectiveness. ECMO-Rehab trial is a registry embedded trial and will be utilising EXCEL data.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2021-08-03; most recent amendment 2024-12-05.
Status change: Recruiting → Active, Not Recruiting 2024-12-05
Status change: Not Yet Recruiting → Recruiting 2022-12-05
Trial Details
NCT Number NCT05003609
Lead Sponsor Australian and New Zealand Intensive Care Research Centre
Collaborators: Monash University, National Health and Medical Research Council, Australia
Conditions Extracorporeal Membrane Oxygenation Complication
Enrollment 100 participants
Start Date 2022-04-27
Primary Completion 2025-05-30 (estimated)
Study Completion 2025-05-30 (estimated)
Updated on ClinicalTrials.gov 2024-12-10